80
Participants
Start Date
June 1, 2023
Primary Completion Date
June 1, 2028
Study Completion Date
June 1, 2032
MACT
"* A biopsy of healthy cartilage is taken from a non-weight bearing area of the knee joint during an arthroscopic procedure.~* The biopsy is processed in the GMP accredited laboratory to isolate and amplify chondrocytes.~* The cells are seeded and cultured on a collagen matrix (Chondro-Gide®, Geistlich Pharma)~* The membrane is implanted and sutured onto the injured site."
AMT
This treatment combines the microfracture procedure with the application of a bilayer matrix of porcine type I/III collagen (Chondro-Gide, Geistlich Pharma) and the supplementation of autologous bone.
Centre Hospitalier Universitaire Vaudois - CHUV, Lausanne
Hôpital Fribourgeois- HFR, Fribourg
Lee Ann LAURENT APPLEGATE
UNKNOWN
Virginie PHILIPPE
UNKNOWN
Centre Hospitalier Universitaire Vaudois
OTHER